These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8815162)

  • 1. Turns-amplitude analysis assessment of myopathies in HIV-infected patients.
    Lefaucheur JP; Verroust J; Gherardi RK
    J Neurol Sci; 1996 Mar; 136(1-2):148-53. PubMed ID: 8815162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 3. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV or zidovudine myopathy?
    Dalakas M
    Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine-associated myopathy.
    Paradis J; Calis KA
    Am J Hosp Pharm; 1994 Dec; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract]   [Full Text] [Related]  

  • 6. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
    Authier FJ; Chariot P; Gherardi RK
    Muscle Nerve; 2005 Sep; 32(3):247-60. PubMed ID: 15902690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic analysis of the electromyographic interference pattern using the turns: amplitude ratio.
    Gilchrist JM; Nandedkar SD; Stewart CS; Massey JM; Sanders DB; Barkhaus PE
    Electroencephalogr Clin Neurophysiol; 1988 Dec; 70(6):534-40. PubMed ID: 2461287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.
    Chariot P; Monnet I; Mouchet M; Rohr M; Lefaucheur JP; Dubreuil-Lemaire ML; Chousterman M; Gherardi R
    Arthritis Rheum; 1994 Apr; 37(4):583-6. PubMed ID: 8147937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic muscle electromyography of levator ani and external anal sphincter in nulliparous women and women with pelvic floor dysfunction.
    Weidner AC; Barber MD; Visco AG; Bump RC; Sanders DB
    Am J Obstet Gynecol; 2000 Dec; 183(6):1390-9; discussion 1399-401. PubMed ID: 11120502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turns-amplitude analysis in normal and myopathic facial muscles.
    Karandreas N; Kararizou E; Papagianni A; Zambelis T; Kokotis P
    Muscle Nerve; 2011 Mar; 43(3):342-7. PubMed ID: 21321950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV or zidovudine myopathy?
    Grau JM; Casademont J
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309595
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor unit reorganization in progressive muscular dystrophies and congenital myopathies.
    Szmidt-Sałkowska E; Gaweł M; Lipowska M
    Neurol Neurochir Pol; 2015; 49(4):223-8. PubMed ID: 26188938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased EMG inhibition following electrical stimulation over muscle tendons in myopathies.
    Priori A; Cinnante C; Pesenti A; Gallanti A; Cappellari A; Scarlato G; Barbieri S
    Clin Neurophysiol; 2001 Oct; 112(10):1931-5. PubMed ID: 11595154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.